Ada Website Helper

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Latinos in Massachusetts worry about rising cost of living and high housing costs

    January 27, 2023

    Pioneer Theater Company Announces Timely World Premiere of ‘A Distinct Society’ – @theU

    January 27, 2023

    Spin Courtney Willis of Spectrum on how DJ training can help people with autism » Dallas Innovates

    January 27, 2023
    Facebook Twitter Instagram
    Ada Website Helper
    • Home
    • Autism

      Spin Courtney Willis of Spectrum on how DJ training can help people with autism » Dallas Innovates

      January 27, 2023

      Jason Kelce and his wife, Kylie, are the driving force behind the Eagles Autism Foundation

      January 27, 2023

      Steinhardt introduces bill to make traffic stops safer for autistic drivers

      January 27, 2023

      “My twin has autism and my son said he didn’t see me as a human being.”

      January 27, 2023

      NIH Program Study Links Prenatal Perfluorononanoic Acid Exposure to Pediatric Autism-Related Features

      January 27, 2023
    • Disabilities

      EEOC Releases Updated Guidance on ADA Requirements for Hearing-Impaired Individuals in the Workplace

      January 27, 2023

      Iowa rest areas getting adult changing rooms to help caregivers of people with disabilities

      January 27, 2023

      Brandt introduces bill to ban organ donation discrimination based on disability

      January 27, 2023

      Learning disabilities – The Economic Times

      January 27, 2023

      Disabled couple happy with accessible OKC Habitat Home

      January 27, 2023
    • Disability

      How do we feel about disability and what are we going to say about it?

      January 27, 2023

      For couples with disabilities, the penalties of marriage are heartbreaking.government opinion

      January 27, 2023

      Retirement and Disability Research Consortium Cooperation Agreement – ​​InsuranceNewsNet

      January 27, 2023

      How executives overcame obstacles and developed a sense of belonging

      January 27, 2023

      Here are the number of people living with a disability in Oxford

      January 27, 2023
    • Literature

      Fusion of art, culture and literature

      January 27, 2023

      Exhibition: A major attraction for art and literary works at the Patiala Heritage Festival

      January 27, 2023

      TETE ATETE Latest Education News with Renowned Translators of Hindi and Urdu Literature | Global Education News

      January 27, 2023

      Didion Dunn archives acquired by the New York Public Library

      January 27, 2023

      Tete Atete with renowned translators of Hindi and Urdu literature – The Times of Bengal

      January 27, 2023
    • Living

      Latinos in Massachusetts worry about rising cost of living and high housing costs

      January 27, 2023

      CT BBB Alert on Cost of Living Fraud

      January 27, 2023

      News and analysis for those planning or nearing retirement

      January 27, 2023

      Living with the Good and Evil of Jordan Poole

      January 27, 2023

      All Saints Abbey of Etna transformed into apartment life

      January 27, 2023
    • Society

      Pioneer Theater Company Announces Timely World Premiere of ‘A Distinct Society’ – @theU

      January 27, 2023

      Philly Mayor Richardson Dilworth Redevelopment Begins

      January 27, 2023

      Las Vegas Ace Star Chelsea Gray Joins Gaming Society Board of Directors

      January 27, 2023

      Purdue Northwest’s Leadership Institute and Society of Innovators Release 2023 Women on the Rise List and Reception – NWILife

      January 27, 2023

      Baird Named President and CEO of NC Aquarium Association

      January 27, 2023
    Facebook Twitter Instagram
    Ada Website Helper
    Home»Autism»Beyond the Landmarks: Where to Next With Biomarkers of Autism?
    Autism

    Beyond the Landmarks: Where to Next With Biomarkers of Autism?

    adawebsitehelper_ts8fwmBy adawebsitehelper_ts8fwmJanuary 1, 202310 Mins Read
    Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    In this issue, the Autism Biomarkers Consortium for Clinical Trials (ABC-CT) offers a landmark contribution to the field of autism science (1). Despite decades of conjecture (2) regarding the empirical status of specific neural markers associated with this clearly neurodevelopmental disorder, no study to date has employed the level of rigor, consistency, and control to directly test core psychometric requirements associated with qualification as a biomarker. The methods utilized in this consortium also offer a primer in scientific humility, as evidenced by the authors’ consistency and registered clarity regarding the criteria required to declare any assay “diagnostic,” still cautiously endorsing specific responses (particularly latency of face-specific event-related potentials [ERPs]) as promising biomarkers for incremental change that may prove useful for clinical trials. In particular, the N170 ERP, a component that is larger and faster in response to faces, the P100 ERP, a marker of exogenous, automatic, early attention, and resting power spectrum slope and gamma activity demonstrated moderate stability over 6 weeks. While group differences did not emerge for every EEG/ERP marker, face memory was associated with faster N170 latency, larger P100 amplitude, lower gamma power, and more negative resting power spectrum slope. In their report on the ABC-CT data, Webb et al. note that the stability of these ERP and EEG markers, lack of discriminant validity between groups, and correlations with phenotypic variables suggest that these potential biomarkers are not suitable for diagnosis, but may be viable inclusion or stratification biomarkers in clinical trials. With this in mind, we hope to augment this discussion of where the field may go—and what pitfalls may arise—as we move forward from this landmark.

    Strengths as Limitations, Directions, and Opportunities

    The rigor of the ABC-CT offers a case study in the double-edged sword of tight controls. On the one hand, confidence in signals obtained across sites can undoubtedly be stronger than even those sought through careful replication. On the other hand, questions of generalization bear consideration after this rigorous investigation. First, do these findings generalize to EEG setups other than the system used by the ABC-CT consortium, including those with sparser arrays, different administration procedures, varying signal processing pipelines, and differing behavioral protocols (3)? These methodological differences may not be trivial: prior work has shown that the error-related negativity (ERN) ERP, a neural index of self-monitoring, such as detecting errors when one commits them, which has been associated with anxiety symptoms, varies in stability by reference, baseline correction, amplitude measurement, and site recordings (4). Could an exploratory approach, such as the one used to assess the ERN, be applied to ERPs of interest in the ABC-CT to enhance the reliability of obtained signals across acquisition methods? A second issue pertains to diversity—both of stimuli and of participants. For instance, it appears that, for the face paradigm, a very small number of faces were used, to reduce variability; however, this introduces questions regarding representation across racial, ethnic, and cultural groups. Relatedly, the stimuli presumably included only neurotypical faces and facial expressions; how might these effects replicate (or not) when the facial stimuli are produced by autistic individuals, given neurotypical difficulties in reading emotions in such faces (5)? Likewise, it is well established that individuals with coarse/curly hair, as is more common in Black/African American populations, are often systematically excluded from EEG studies (6), particularly when standardized dense arrays are used. Can these paradigms be applied to sparser array setups to increase diversity?

    The ABC-CT shows that it is possible to obtain reliable signals across sites using tight controls; however, evidence of the robustness of these signals will depend on future work increasing the diversity of equipment, stimuli, and participants. These questions grow larger when we begin to consider the future of ERP research (2) and accessibility of clinical trials to people from all backgrounds, where it is likely that increasing use of portable EEG setups will give way to in vivo measurement of the components identified by Webb et al. Will these components retain their psychometric strength in this setting? More generally, to what in vivo social behaviors do the obtained components map on—and what does this tell us about the ecological validity of these components?

    Potential of Potentials for Clinical Trials

    Of course, the stated aim of the ABC-CT is to identify biomarkers of autism that can be useful for clinical trials. Latency of P1 and N170 ERPs to faces were identified as the most promising candidates. This, though, quickly begs practical follow-up questions regarding the parameters of those clinical trials. First, especially given the fact that these biomarkers were not found to yield diagnostic differentiation, it is important to determine: clinical trials for whom? Are these biomarkers meant to be useful for those who meet diagnostic criteria for autism spectrum disorder (ASD), or a specific clinical or demographic subset of the population (e.g., older youths, or those with face memory challenges, given the phenotype correlations obtained)? Might the answer to this question vary as a function of race, ethnicity, language, or other intersectional factors that otherwise led to the historical exclusion of subgroups of the population (7)? Are these biomarkers applicable to individuals who (at specific times or in discrete contexts) pass as nonautistic (8)?

    Second, what kind of intervention might be especially amenable to impacting these ERPs? While there is some evidence that the N170, at least, may show change during randomized controlled trials of performance-based social interventions for adolescents (9), these data bear replication and extension. How might these effects vary, however, as a function of age (e.g., early intervention or adult supports), and intensity (i.e., what might be the dosage threshold necessary to elicit change)?

    Third, the results reported by Webb et al. offer intriguing opportunities for exploration regarding which biomarkers may translate best to which type of intervention. For instance, while face-responsive ERPs were related to several social phenotypic variables (e.g., face memory, adaptive functioning scores), suggesting that they may be promising as biomarkers of these outcomes, data loss was higher (77%) for this task, and was related to several indices of functioning. Since autistic youths with greater social functioning difficulties are most likely to need—and enroll in—social interventions, how do we resolve this confounder? For individuals with more restricted and repetitive behaviors, resting-state gamma power or power spectrum slopes may hold more promise given the decrease in data loss (86%), which was unassociated with restricted and repetitive behaviors, and therefore could potentially be used in interventions designed to enhance flexibility (10). Findings from the ABC-CT highlight that biomarkers are likely not “one size fits all,” and instead provide a first step in identifying which biomarker may be appropriate for a given intervention and a specific child.

    Finally, and perhaps most important, how can we leverage biomarkers to learn about mechanism of change in interventions (11)? In the imagined scientific ideal, we would wish to say that specific ERPs tell us about specific processes in interventions (e.g., an intervention that affects social functioning by engaging and improving attention to faces may be hypothesized to yield change in a specific facial attention-linked ERP that is detectable during the course of the intervention, and in turn mediates the relationship between condition assignment and social functioning outcomes). However, the actual on-line function of any given ERP (i.e., its manifestation in vivo if obtained during real-world activities) may be far more dynamic—particularly in the course of a clinical trial—than these static constructs suggest. It will thus be vital to use both clinical trial methodologies (e.g., dismantling designs) and statistical approaches (e.g., multilevel growth models that allow for modeling within- and between-person change in tandem) that allow for testing such dynamics.

    The ABC-CT supported further assessment of three paradigms (faces, VEP, and resting-state) to determine whether markers from these paradigms may be useful in clinical trials of autism. Although EEG and ERP markers from these experiments were not determined to be promising diagnostic biomarkers, many of these markers showed reliability and stability and correlated with phenotypic outcomes (e.g., face memory and parent-report measures) indicating that they may provide utility as inclusion or stratification markers; this was particularly the case for those obtained during the faces paradigm. Overall, these landmark findings from the ABC-CT both provide some foundational answers to key psychometric questions about potential biomarkers of autism, and invite many more new questions—opening new vistas of the landscape. Perhaps the search for these elusive psychiatric biomarkers can tell us more than we had thought—but also less than we had hoped. These findings fundamentally highlight the importance of further bridging the study of key complex social outcomes across levels of analysis (12) to ultimately reveal their practical potential.

    Department of Psychology, Stony Brook University, Stony Brook, N.Y.

    Dr. Lerner receives support from NIMH (grant R01MH110585; principal investigator, Dr. Lerner), the Health Resources and Services Administration (grant T73MC42026; principal investigator, Michelle Ballan, Ph.D.), and the Simons Foundation (grant 1002936; principal investigator, Dr. Lerner).

    The authors report no financial relationships with commercial interests.

    References

    1. Webb SJ, Naples AJ, Levin AR, et al.: The Autism Biomarkers Consortium for Clinical Trials: initial evaluation of a battery of candidate EEG biomarkers. Am J Psychiatry 2023; 180:41–49Abstract, Google Scholar

    2. McPartland JC, Lerner MD, Bhat A, et al.: Looking back at the next 40 years of ASD neuroscience research. J Autism Dev Disord 2021; 51:4333–4353Crossref, Medline, Google Scholar

    3. Webb SJ, Bernier R, Henderson HA, et al.: Guidelines and best practices for electrophysiological data collection, analysis, and reporting in autism. J Autism Dev Disord 2015; 45:425–443Crossref, Medline, Google Scholar

    4. Sandre A, Banica I, Riesel A, et al.: Comparing the effects of different methodological decisions on the error-related negativity and its association with behaviour and gender. Int J Psychophysiol 2020; 156:18–39Crossref, Medline, Google Scholar

    5. Brewer R, Biotti F, Catmur C, et al.: Can neurotypical individuals read autistic facial expressions? Atypical production of emotional facial expressions in autism spectrum disorders. Autism Res 2016; 9:262–271Crossref, Medline, Google Scholar

    6. Choy T, Baker E, Stavropoulos K: Systemic racism in EEG research: considerations and potential solutions. Affect Sci 2022; 3:14–20Crossref, Medline, Google Scholar

    7. Cascio MA, Weiss JA, Racine E: Making autism research inclusive by attending to intersectionality: a review of the research ethics literature. Rev J Autism Dev Disord 2021; 8:22–36Crossref, Google Scholar

    8. Libsack EJ, Keenan EG, Freden CE, et al.: A systematic review of passing as non-autistic in autism spectrum disorder. Clin Child Fam Psychol Rev 2021; 24:783–812Crossref, Medline, Google Scholar

    9. Kang E, Keifer C, Clarkson T, et al.: Electrophysiological changes following a blinded randomized controlled trial of a social competence intervention for youth with ASD (abstract). J Am Acad Child Adolesc Psychiatry 2019; 58:S322Crossref, Google Scholar

    10. Scarpa A, Swain DM, Factor RS, et al.: Enhancing flexibility: a biosocial model for resilience to adversity in youth with autism. SAGE Open 2021; 11:21582440211037996Crossref, Google Scholar

    11. Lerner MD, White SW, McPartland JC: Mechanisms of change in psychosocial interventions for autism spectrum disorders. Dialogues Clin Neurosci 2012; 14:307–318Crossref, Medline, Google Scholar

    12. Clarkson T, Kang E, Capriola-Hall N, et al.: Meta-analysis of the RDoC social processing domain across units of analysis in children and adolescents. J Clin Child Adolesc Psychol 2020; 49:297–321Crossref, Medline, Google Scholar



    Source link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
    adawebsitehelper_ts8fwm
    • Website

    Related Posts

    Autism January 27, 2023

    Spin Courtney Willis of Spectrum on how DJ training can help people with autism » Dallas Innovates

    Autism January 27, 2023

    Jason Kelce and his wife, Kylie, are the driving force behind the Eagles Autism Foundation

    Autism January 27, 2023

    Steinhardt introduces bill to make traffic stops safer for autistic drivers

    Autism January 27, 2023

    “My twin has autism and my son said he didn’t see me as a human being.”

    Autism January 27, 2023

    NIH Program Study Links Prenatal Perfluorononanoic Acid Exposure to Pediatric Autism-Related Features

    Autism January 27, 2023

    NIH Program Study Links Prenatal Perfluorononanoic Acid Exposure to Pediatric Autism-Related Features

    Leave A Reply Cancel Reply

    Don't Miss
    Living January 27, 2023

    Latinos in Massachusetts worry about rising cost of living and high housing costs

    A significant number of Massachusetts Latinx residents feel the disproportionate effects of racial and economic…

    Pioneer Theater Company Announces Timely World Premiere of ‘A Distinct Society’ – @theU

    January 27, 2023

    Spin Courtney Willis of Spectrum on how DJ training can help people with autism » Dallas Innovates

    January 27, 2023

    How do we feel about disability and what are we going to say about it?

    January 27, 2023
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    About Us

    This website provides information about disability and other things. Keep Supporting Us With the Latest News and we Will Provide the Best Of Our To Makes You Updated All Around The World News. Keep Sporting US.

    Our Picks

    Latinos in Massachusetts worry about rising cost of living and high housing costs

    January 27, 2023

    Pioneer Theater Company Announces Timely World Premiere of ‘A Distinct Society’ – @theU

    January 27, 2023

    Spin Courtney Willis of Spectrum on how DJ training can help people with autism » Dallas Innovates

    January 27, 2023

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    Facebook Twitter Instagram Pinterest
    • Home
    • Contact us
    • DMCA
    • Privacy Policy
    © 2023 adawebsitehelper. Designed b yadawebsitehelper.

    Type above and press Enter to search. Press Esc to cancel.